UniQure’s Glybera Wins EU Backing as First Gene Therapy

Europe is on the cusp of approving the first gene therapy to be sold on the market in a western nation, a product from UniQure BV designed to treat a rare disease that disrupts fat production in the body.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.